99% Failure Rate

Be still my beating heart.  One day after writing a blog post describing how taking a statin for six years gives you three or four more days of life, CNN publishes an article titled, “Global study lays groundwork for daily statin usage to prevent heart disease.” (1)   This study is referred to as the HOPE-3 trial.  The author of the CNN article was summarizing the findings from a New England Journal of Medicine Study released today.  (2)

(BTW:  This study was funded by Big Pharma Cartel member AstraZeneca who, you guessed it, makes Crestor—the statin drug used in the study.)

Could I be wrong?  I have been stating that statins fail nearly 99% who take them, yet the CNN article stated that those who took Crestor (when compared to those that took a placebo) for nearly six years had a 24% reduction in heart attacks, strokes or heart-related deaths.  Furthermore, the authors of the study stated, “The HOPE-3 trial provides evidence to reinforce some current guideline recommendations and to influence future guidelines.” 

The post 99% Failure Rate appeared first on LewRockwell.